Matthew Walter

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Myelodysplastic Syndromes 81%
3. Mutation 73%
4. GATA2 Deficiency 40%
5. Genes 32%
6. Leukemia 29%
7. Neoplasms 26%
8. Genome 24%
9. Spliceosomes 24%
10. Acute Promyelocytic Leukemia 22%
11. Whole Genome Sequencing 21%
12. Hematopoietic Stem Cells 21%
13. Hematopoiesis 18%
14. Clone Cells 18%
15. Myeloid Cells 16%
16. RNA Precursors 15%
17. High-Throughput Nucleotide Sequencing 15%
18. Haploinsufficiency 14%
19. Bone Marrow 14%
20. RNA Splicing Factors 12%
21. Clonal Evolution 10%
22. B-Lymphocytes 10%
23. Karyotype 9%
24. Penetrance 9%
25. Human T-lymphotropic virus 1 8%
26. Recurrence 8%
27. Therapeutics 8%
28. Retinoic Acid Receptors 8%
29. Granulocyte Precursor Cells 8%
30. DNA Damage 8%
31. Bone Marrow Cells 8%
32. Hematologic Neoplasms 8%
33. Lymphopoiesis 7%
34. Protein Isoforms 7%
35. Exome 7%
36. Epigenomics 7%
37. Familial Acute Myeloid Leukemia with Mutated Cebpa 7%
38. DNA 7%
39. Tropical Spastic Paraparesis 7%
40. DNA Methylation 6%
41. R-Loop Structures 6%
42. Cytogenetics 6%
43. RNA-Seq 6%
44. Chromosomes, Human, Pair 2 6%
45. In Situ Hybridization 6%
46. Drug Therapy 6%
47. STAT5 Transcription Factor 6%
48. Decitabine 5%
49. Alternative Splicing 5%
50. Interleukin-1 Receptor-Associated Kinases 5%